Health Robotics Announces $60M Investment by Devon International Group and ITOCHU Inc. in the CytoCare(TM) and i.v.Station(TM PENDI...(itical area of cancer care medication er...)

Date:11/21/2008

itical area of cancer care, medication errors can mean the difference between life and death. CytoCare(TM)'s state-of-the-art robotics technology eliminates human handling of chemotherapy and other hazardous drugs during preparation, greatly improves accuracy, and reduces potentially fatal medication errors, and has changed the ways pharmacists and hospitals administer cancer therapies," says John A. Bennett, president of Devon International Group. "Increased safety for patients and clinicians, higher accuracy of IV Admixtures, reduced waste, and improved efficiency of hospitals' pharmacy workflow are among the key benefits of both CytoCare(TM) and i.v.Station(TM)pending. We are proud to become strategic partners with such an innovative, forward-thinking company and indeed share Health Robotics' vision to utilize robotics technology to improve patient care. We look forward to working with hospitals, cancer centers, and their pharmacy staffs to make CytoCare and i.v.Station(TM)pending the gold standards for IV Admixture automation in North America."

"We have developed and deployed the only totally automated system for safe handling and preparation of hazardous IV admixtures in the world, and are extremely proud to be making a significant advancement in patient safety and clinician safety in Europe," says Werner Rainer, CEO of Health Robotics. "We are ecstatic that Devon International Group will be our largest strategic partner to date and the first partner to ever acquire an equity stake in the company, as their expertise in healthcare, information technology, and the global business environment will help us connect with hospitals and oncology centers. The addition to Dr. Bennett to our Board of Directors will greatly enhance our understanding of customers' needs in North America and Asia."

About Devon International Group

The Devon International Group (DIG) is a multi-national group of companies spanni
'/>"/>

SOURCE Health Robotics Copyright©2008 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4
Related biology technology :

1. BioSpecifics Technologies Corp. to Present at Piper Jaffray 20th Annual Health Care Conference
2. Neurocrine Biosciences to Present at the 20th Annual Piper Jaffray Health Care Conference
3. American HealthChoice Announces the First Sales of the OmniBody Scan
4. Jazz Pharmaceuticals Cancels Presentation Planned for November 19, 2008 at Lazard Capital Markets 5th Annual Healthcare Conference
5. Bavarian Nordic Receives USD 25 Million Milestone Payment After Submission of Important IMVAMUNE(R) Data to The U.S. Health Authorities
6. Mexican Department of Public Health to Launch Screening for Human Papillomavirus (HPV), Cause of Cervical Cancer
7. HEALTHeCAREERS Network Pledges $15,000 to ASRT Foundation for Professional Healthcare Training
8. Savient Pharmaceuticals to Present at the Lazard Capital Markets 5th Annual Healthcare Conference on November 18th
9. Gen-Probe to Webcast Presentation at the Lazard Capital Markets 5th Annual Healthcare Conference
10. Frost & Sullivan Presents CorMatrix Cardiovascular Inc. with 2008 Healthcare Innovation Award for the Treatment of Cardiovascular Disease
11. Beckman Coulter to Present at the Lazard Capital Markets 5th Annual Healthcare Conference